These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 9781014

  • 21. Genetic causes of familial hypercholesterolaemia in a Malaysian population.
    Khoo KL, Van Acker P, Tan H, Deslypere JP.
    Med J Malaysia; 2000 Dec; 55(4):409-18. PubMed ID: 11221151
    [Abstract] [Full Text] [Related]

  • 22. Impact of markedly elevated serum lipoprotein(a) levels (> or = 100 mg/dL) on the risk of coronary heart disease.
    Murase T, Okubo M, Amemiya-Kudo M, Hiraga T, Oka J, Shimada M, Igarashi T.
    Metabolism; 2007 Sep; 56(9):1187-91. PubMed ID: 17697860
    [Abstract] [Full Text] [Related]

  • 23. Familial hypercholesterolemia and familial defective apolipoprotein B-100: comparison of the phenotypic expression In 116 cases.
    Brugger D, Schuster H, Zöllner N.
    Eur J Med Res; 1996 May 24; 1(8):383-6. PubMed ID: 9360938
    [Abstract] [Full Text] [Related]

  • 24. Characterization and geographic distribution of the low density lipoprotein receptor (LDLR) gene mutations in northwestern Greece.
    Miltiadous G, Elisaf M, Bairaktari H, Xenophontos SL, Manoli P, Cariolou MA.
    Hum Mutat; 2001 May 24; 17(5):432-3. PubMed ID: 11317361
    [Abstract] [Full Text] [Related]

  • 25. Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholesterolemia kindred.
    Takada D, Emi M, Ezura Y, Nobe Y, Kawamura K, Iino Y, Katayama Y, Xin Y, Wu LL, Larringa-Shum S, Stephenson SH, Hunt SC, Hopkins PN.
    J Hum Genet; 2002 May 24; 47(12):656-64. PubMed ID: 12522687
    [Abstract] [Full Text] [Related]

  • 26. Genetics and metabolism of lipoprotein(a) and their clinical implications (Part 1).
    Dieplinger H, Kronenberg F.
    Wien Klin Wochenschr; 1999 Jan 15; 111(1):5-20. PubMed ID: 10067265
    [Abstract] [Full Text] [Related]

  • 27. [Mutation screening and functional analysis of low density lipoprotein receptor in a familial hypercholesterolemia family].
    Cheng XH, Zheng F, Zhou X, Xiong CL, Ding J, Chen YM.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb 15; 25(1):55-8. PubMed ID: 18247305
    [Abstract] [Full Text] [Related]

  • 28. FH clinical phenotype in Greek patients with LDL-R defective vs. negative mutations.
    Dedoussis GV, Skoumas J, Pitsavos C, Choumerianou DM, Genschel J, Schmidt H, Stefanadis C.
    Eur J Clin Invest; 2004 Jun 15; 34(6):402-9. PubMed ID: 15200491
    [Abstract] [Full Text] [Related]

  • 29. [Lipoprotein(a) in heterozygote familial hypercholesterolemia].
    Ochoa Sosa CA, Zamora González J, González Hermosillo JA, Ize Lema I, Cardoso Saldaña G, Posadas Romero C.
    Arch Inst Cardiol Mex; 1994 Jun 15; 64(6):549-55. PubMed ID: 7726691
    [Abstract] [Full Text] [Related]

  • 30. Family study in familial hypercholesterolemia with a receptor-negative homozygous 9-year-old boy.
    Clemens P, Beisiegel U, Steinhagen-Thiessen E.
    Helv Paediatr Acta; 1986 Aug 15; 41(3):173-82. PubMed ID: 2944857
    [Abstract] [Full Text] [Related]

  • 31. Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation.
    Alonso R, Andres E, Mata N, Fuentes-Jiménez F, Badimón L, López-Miranda J, Padró T, Muñiz O, Díaz-Díaz JL, Mauri M, Ordovás JM, Mata P, SAFEHEART Investigators.
    J Am Coll Cardiol; 2014 May 20; 63(19):1982-9. PubMed ID: 24632281
    [Abstract] [Full Text] [Related]

  • 32. Effect of apolipoprotein E genotype on lipid levels and response to diet in familial hypercholesterolemia.
    Carmena-Ramón R, Real JT, Ascaso JF, Ordovás JM, Carmena R.
    Nutr Metab Cardiovasc Dis; 2000 Feb 20; 10(1):7-13. PubMed ID: 10812582
    [Abstract] [Full Text] [Related]

  • 33. Lipoprotein Lp(a) in homozygous familial hypercholesterolemia: density profile, particle heterogeneity and apolipoprotein(a) phenotype.
    Guo HC, Chapman MJ, Bruckert E, Farriaux JP, De Gennes JL.
    Atherosclerosis; 1991 Jan 20; 86(1):69-83. PubMed ID: 1829609
    [Abstract] [Full Text] [Related]

  • 34. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M, Biri A, Bukan N, Karakoç A, Sancak B, Törüner F, Paşaoğlu H.
    Gynecol Endocrinol; 2005 May 20; 20(5):258-63. PubMed ID: 16019370
    [Abstract] [Full Text] [Related]

  • 35. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.
    Sandholzer C, Boerwinkle E, Saha N, Tong MC, Utermann G.
    J Clin Invest; 1992 Mar 20; 89(3):1040-6. PubMed ID: 1541665
    [Abstract] [Full Text] [Related]

  • 36. The relationship among apolipoprotein(a) polymorphisms, the low-density lipoprotein receptor-related protein, and the very low density lipoprotein receptor genes, and plasma lipoprotein(A) concentration in the Czech population.
    Benes P, Muzík J, Benedík J, Znojil V, Vácha J.
    Hum Biol; 2002 Feb 20; 74(1):129-36. PubMed ID: 11931574
    [Abstract] [Full Text] [Related]

  • 37. The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans.
    Rader DJ, Mann WA, Cain W, Kraft HG, Usher D, Zech LA, Hoeg JM, Davignon J, Lupien P, Grossman M.
    J Clin Invest; 1995 Mar 20; 95(3):1403-8. PubMed ID: 7883987
    [Abstract] [Full Text] [Related]

  • 38. Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.
    Zambon A, Brown BG, Deeb SS, Brunzell JD.
    J Intern Med; 2006 May 20; 259(5):473-80. PubMed ID: 16629853
    [Abstract] [Full Text] [Related]

  • 39. HDL cholesterol levels in patients with molecularly defined familial hypercholesterolemia.
    Miltiadous G, Cariolou MA, Elisaf M.
    Ann Clin Lab Sci; 2002 May 20; 32(1):50-4. PubMed ID: 11848618
    [Abstract] [Full Text] [Related]

  • 40. [Elevated levels of lipoprotein(a) are present in subjects with early ischemic cardiopathy and with a familial history of ischemic cardiopathy].
    Saitta A, Castaldo M, Sardo A, Cinquegrani M, Bonaiuto M, Zema M, Gravina M, Mangano C.
    Minerva Med; 1999 May 20; 90(5-6):151-8. PubMed ID: 10780189
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.